Jerome Jabbour | executive |
Keith Kucinski | executive |
Scott Henry | analyst |
Theresa Matkovits | executive |
Rei Tan | analyst |
Welcome, everyone, to the Matinas BioPharma First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead.
This is Jody Cain with LHA Investor Relations. Thank you for participating in today's call.